LAUREN CARRA: Open Payments
NPI 1831530609 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,492 in 114 payments from 20 companies in 2025. Trend: 2023 $2,719 · 2024 $2,483 · 2025 $2,492
Food & beverage: $2,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $856 |
| AstraZeneca Pharmaceuticals LP | 16 | $344 |
| Novo Nordisk Inc | 11 | $246 |
| Phathom Pharmaceuticals, Inc. | 9 | $188 |
| PFIZER INC. | 6 | $134 |
| Lilly USA, LLC | 5 | $121 |
| Axsome Therapeutics, Inc. | 3 | $97 |
| Astellas Pharma US Inc | 3 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Amgen Inc. | 3 | $66 |
Products named: UBRELVY, VRAYLAR, VOQUEZNA, AIRSUPRA, Wegovy, NURTEC ODT, FARXIGA, MOUNJARO.
Industry payments across MA — which companies pay providers there.
